Financhill
Buy
76

HOTH Quote, Financials, Valuation and Earnings

Last price:
$2.26
Seasonality move :
-27.22%
Day range:
$1.44 - $3.80
52-week range:
$0.58 - $3.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.10x
Volume:
415.7M
Avg. volume:
14.3M
1-year change:
67.65%
Market cap:
$15.7M
Revenue:
--
EPS (TTM):
-$1.32

Earnings Data

Next earnings date for HOTH
May 14
2025
Most recent earnings per share
-$0.31
Missed by $0.01
(Nov 12/2024)
Consensus Estimate
-$0.30
(Nov 12/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

HOTH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/14/2025 Q1 -- -- -- -$0.25 --
12/31/2024 Q4 -- -- -- -$0.47 --
11/12/2024 Q3 -- -- -$0.31 -$0.30 -$0.01
08/09/2024 Q2 -- -- -$0.24 -$0.43 $0.19
05/14/2024 Q1 -- -- -$0.46 -$0.43 -$0.03
12/31/2023 Q4 -- -- -$0.31 -$0.51 $0.20
11/13/2023 Q3 -- -- -$0.60 -$0.73 $0.13
06/30/2023 Q2 -- -- -$0.57 -$1.16 $0.59
03/31/2023 Q1 -- -- -$0.88 -$0.87 -$0.02
12/31/2022 Q4 -- -- -$2.72 -$1.94 -$0.79
11/10/2022 Q3 -- -- -$2.05 -$2.43 $0.38
08/11/2022 Q2 -- -- -$2.16 -- --
05/13/2022 Q1 -- -- -$2.68 -- --
03/16/2022 Q4 -- -- -$3.58 -- --
11/10/2021 Q3 -- -- -$3.45 -- --
08/11/2021 Q2 -- -- -$3.50 -- --
05/13/2021 Q1 -- -- -$6.00 -- --
12/31/2020 Q4 -- -- -$1.00 -- --
11/10/2020 Q3 -- -- -$4.00 -- --
08/13/2020 Q2 -- -- -$5.00 -- --
05/13/2020 Q1 -- -- -$4.50 -- --
02/14/2020 Q4 -- -- -$10.25 -- --
11/12/2019 Q3 -- -- -$4.25 -- --
06/30/2019 Q2 -- -- -$3.25 -- --
03/31/2019 Q1 -- -- -$3.00 -- --
12/31/2018 Q4 -- -- -$1.55 -- --
09/30/2018 Q3 -- -- -$1.65 -- --
06/30/2018 Q2 -- -- -$2.03 -- --
03/31/2018 Q1 -- -- -$1.40 -- --

Hoth Therapeutics Earnings Questions

  • How Much did Hoth Therapeutics Generate in Revenue Last Quarter?

    Hoth Therapeutics reported -- worth of top line sales in its most recent quarter.

  • Did Hoth Therapeutics Beat Earnings Last Quarter?

    Hoth Therapeutics announced earnings per share of -$0.31 which represents a miss of analyst forecast a -$0.30 per share.

  • Is Hoth Therapeutics Profitable?

    Hoth Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Hoth Therapeutics EPS Next Year?

    Hoth Therapeutics's earnings are forecast to decrease from -$2.30 per share to -$1.54 per share next year representing a decrease of -33.04%.

  • When is Hoth Therapeutics's Earnings Date?

    Hoth Therapeutics's next earnings date is May 14, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is SCHD a Good ETF to Buy?
Is SCHD a Good ETF to Buy?

With around $65.7 billion in net assets, Schwab’s US Dividend…

Is NAIL a Good ETF to Buy?
Is NAIL a Good ETF to Buy?

If you’re thinking about buying the NAIL ETF, this article…

3 High Dividend Dow Jones Stocks
3 High Dividend Dow Jones Stocks

Thanks to surging stock prices over the past two years,…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
43
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Buy
57
NARI alert for Jan 8

Inari Medical [NARI] is up 22.25% over the past day.

Buy
69
UNF alert for Jan 8

UniFirst [UNF] is up 20.59% over the past day.

Sell
31
APOG alert for Jan 8

Apogee Enterprises [APOG] is down 19.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock